Ongoing clinical development of lapatinib in HER2-positive (HER2+) metastatic breast cancer (MBC): An innovative approach to recruit patients in clinical studies.
S. R. D. Johnston
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
K. A. Gelmon
Research Funding - GlaxoSmithKline (B)
X. B. Pivot
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Roche; Sanofi
Honoraria - GlaxoSmithKline; Novartis; PharmaMar; Roche; Sanofi
W. J. Gradishar
Consultant or Advisory Role - GlaxoSmithKline
A. Conner
Employment or Leadership Position - GlaxoSmithKline
D. Kothari
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
P. Legenne
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
M. Leigh
Employment or Leadership Position - GlaxoSmithKline
L. O'Rourke
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
R. Parikh
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline